234 related articles for article (PubMed ID: 32709660)
1. Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.
Anderson KM; Augusto DG; Dandekar R; Shams H; Zhao C; Yusufali T; Montero-Martín G; Marin WM; Nemat-Gorgani N; Creary LE; Caillier S; Mofrad MRK; Parham P; Fernández-Viña M; Oksenberg JR; Norman PJ; Hollenbach JA
J Immunol; 2020 Sep; 205(5):1323-1330. PubMed ID: 32709660
[TBL] [Abstract][Full Text] [Related]
2. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
3. HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
Wang R; Sun Y; Kuang BH; Yan X; Lei J; Lin YX; Tian J; Li Y; Xie X; Chen T; Zhang H; Zeng YX; Zhao J; Feng L
Emerg Microbes Infect; 2023 Dec; 12(1):2185467. PubMed ID: 36849422
[TBL] [Abstract][Full Text] [Related]
4. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
5. HLA alleles determine differences in human natural killer cell responsiveness and potency.
Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.
Erbe AK; Wang W; Carmichael L; Hoefges A; Grzywacz B; Reville PK; Ranheim EA; Hank JA; Kim K; Seo S; Mendonca EA; Song Y; Kenkre VP; Hong F; Gascoyne RD; Paietta E; Horning SJ; Miller JS; Kahl B; Sondel PM
J Immunother Cancer; 2019 Mar; 7(1):70. PubMed ID: 30871628
[TBL] [Abstract][Full Text] [Related]
7. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection.
Mele D; Pasi A; Cacciatore R; Mantovani S; Oliviero B; Mondelli MU; Varchetta S
Liver Int; 2019 Jul; 39(7):1237-1245. PubMed ID: 31177636
[TBL] [Abstract][Full Text] [Related]
8. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
[TBL] [Abstract][Full Text] [Related]
9. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
10. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
Boudreau JE; Giglio F; Gooley TA; Stevenson PA; Le Luduec JB; Shaffer BC; Rajalingam R; Hou L; Hurley CK; Noreen H; Reed EF; Yu N; Vierra-Green C; Haagenson M; Malkki M; Petersdorf EW; Spellman S; Hsu KC
J Clin Oncol; 2017 Jul; 35(20):2268-2278. PubMed ID: 28520526
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
12. Association of variably expressed KIR3dl1 alleles with psoriatic disease.
Berinstein J; Pollock R; Pellett F; Thavaneswaran A; Chandran V; Gladman DD
Clin Rheumatol; 2017 Oct; 36(10):2261-2266. PubMed ID: 28801811
[TBL] [Abstract][Full Text] [Related]
13. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of KIR3DL1 expression levels on 92 cases of normal donors for hematopoietic stem cells transplant].
Zhang J; Wang M; Bao X; Wu X; Zhou H; Zhang H; Wu D; He J
Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):994-8. PubMed ID: 26759099
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
16. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
[TBL] [Abstract][Full Text] [Related]
18. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
[TBL] [Abstract][Full Text] [Related]
19. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease.
Castaño-Núñez Á; Montes-Cano MA; García-Lozano JR; Ortego-Centeno N; García-Hernández FJ; Espinosa G; Graña-Gil G; Sánchez-Bursón J; Juliá MR; Solans R; Blanco R; Barnosi-Marín AC; Gómez de la Torre R; Fanlo P; Rodríguez-Carballeira M; Rodríguez-Rodríguez L; Camps T; Castañeda S; Alegre-Sancho JJ; Martín J; González-Escribano MF
Front Immunol; 2019; 10():2755. PubMed ID: 31849952
[TBL] [Abstract][Full Text] [Related]
20. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
